Table 4.
Percentage of inhibition of the Spike:ACE2 binding.
| % of Binding Inhibition | ||||
|---|---|---|---|---|
| Patient ID | Antibody Title | 5 μL of Serum | 10 μL of Serum | 20 μL of Serum |
| 1 | 96.6 AU/mL | 98.6 | 99.5 | 99.6 |
| 2 | 170 AU/mL | 99.3 | 99.4 | 99.3 |
| 3 | 89.4 AU/mL | 98.1 | 99.3 | 99.4 |
| 4 | 125 AU/mL | 98.8 | 99.3 | 99.4 |
| 5 | 146 AU/mL | 95.7 | 96.9 | 97.3 |
Serum efficacy has been calculated in ACE2:SARS-CoV-2 Spike Inhibitor Screening Assay Kit as percent of inhibition of Spike RBD binding to ACE2 binding obtained using SPIKE at 5 nM, arbitrarily set as 100%.